Capricor Therapeutics, Inc. (CAPR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -29.25M | -23.57M | -19.69M | -20.12M | -6.43M | -14.8M | -11.64M | -12.29M | -1.27M | -11.59M | -8.79M | -9.42M |
| Operating CF Margin % | - | - | - | - | - | -132.93% | -514.78% | -309.42% | -25.85% | -95.91% | -142.18% | -240.4% |
| Operating CF Growth % | -354.73% | -59.27% | -69.11% | -63.75% | -407.2% | -27.62% | -32.38% | -30.48% | -130.13% | -67.98% | -54.69% | -43.95% |
| Net Income | -33.94M | -80.65B | 0 | -25.91M | -24.39M | -7.12M | -12.56M | -11M | -9.79M | -762.09K | -6.39M | -7.37M |
| Depreciation & Amortization | 534.67K | 1B | 246.74M | 486.28K | 405.45K | 375.7K | 361.17K | 356.94K | 331.41K | 307.61K | 276.47K | 254.7K |
| Stock-Based Compensation | 0 | -3.39B | 7.37B | 3.65M | 5.74M | 2.3M | 2.05M | 2.15M | 3.27M | 1.86M | 1.72M | 1.62M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.84M | 5.39K | 0 |
| Other Non-Cash Items | 6.19M | 83.02B | -7.64B | -16.84K | 133.83K | 96.48K | -347.63K | -10.1K | -10.1K | 12.83M | -1.02K | -6.45K |
| Working Capital Changes | -2.04M | -1.16M | 5.66K | 1.67M | 11.68M | -10.45M | -1.15M | -3.79M | 4.94M | -12.99M | -4.4M | -3.92M |
| Change in Receivables | 59.17K | 0 | 342 | 325 | 10.31M | -9.96M | 9.95B | -975 | 10M | -9.82M | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -3.08M | 2.17M | 971.65K | 1.53M | 1.32M | 0 | 281.12M | 0 | -1.58K | -541.71K | 1.66M | -291.92K |
| Cash from Investing | -154.64M | 43.09M | 15.95M | 14.55M | 23.89M | -123.38M | 2M | 14.7M | -9.5M | -5.86M | 7.72M | 6.46M |
| Capital Expenditures | -10.75M | -2.01B | -4.01M | -1.45M | -1.14M | -734.72K | -677.33M | -80.91K | -664.32K | -729.22K | -631.75K | -233.44K |
| CapEx % of Revenue | - | - | - | - | - | 6.6% | 29948.5% | 2.04% | 13.54% | 6.03% | 10.21% | 5.96% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.13M | -8.35M | -6.69M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -82.12B | 0 | 0 | 0 | 0 | 69.69B | 0 | 0 | -5.13M | 8.35M | 6.69M |
| Cash from Financing | 1.47M | 248.82M | 6.95K | 19.58K | 50.35K | 81.09M | 67.33M | 2.07M | 2.29M | 23.17M | 221.08K | 2.19M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1.47M | 248.82M | 6.95K | 19.58K | 50.35K | 80.84M | 67.21M | 1.99M | 2.29M | 23.16M | 221.08K | 2.13M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 247.96K | 121K | 81.22K | 0 | 3.03K | 0 | 57.68K |
| Net Change in Cash | -182.43M | 268.34M | -3.73M | -5.55M | 17.51M | -57.09M | 57.69M | 4.47M | -8.48M | 5.71M | -852.47K | -768.39K |
| Free Cash Flow | -40M | -28.69M | -23.7M | -21.57M | -7.57M | -15.53M | -11.7M | -12.37M | -1.93M | -12.32M | -9.43M | -9.65M |
| FCF Margin % | - | - | - | - | - | -139.54% | -517.39% | -311.46% | -39.39% | -101.95% | -152.39% | -246.36% |
| FCF Growth % | -428.16% | -84.74% | -102.52% | -74.4% | -291.87% | -26.03% | -24.13% | -28.16% | -151.44% | -51.68% | -38.93% | -38.77% |
| FCF per Share | -0.70 | -0.59 | -0.52 | -0.47 | -0.17 | -0.44 | -0.35 | -0.39 | -0.06 | -0.46 | -0.37 | -0.38 |
| FCF Conversion (FCF/Net Income) | 0.86x | 0.78x | 0.80x | 0.78x | 0.26x | 2.08x | 0.93x | 1.12x | 0.13x | 15.21x | 1.38x | 1.28x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |